Active Stocks : Alcatel Lucent SA (ADR) (NYSE:ALU), Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), Gray Television Inc. (NYSE:GTN), Nokia Corporation (ADR) (NYSE:NOK), AT&T, Inc. (NYSE:T)

Telecoms gear maker Alcatel Lucent SA (ADR) (NYSE:ALU) suffered a fall of 5.9 percent in third-quarter sales and delivered a net loss of 18 million euros in a tough market for the industry, but squeezed out more costs to improve its gross profit margin to 34 percent from 31.9 percent a year earlier. Alcatel Lucent SA (ADR) (NYSE:ALU) belongs to Technology sector. Its net profit … Continue reading Active Stocks : Alcatel Lucent SA (ADR) (NYSE:ALU), Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), Gray Television Inc. (NYSE:GTN), Nokia Corporation (ADR) (NYSE:NOK), AT&T, Inc. (NYSE:T)

Chris Lewis10/3010/30

Trending Stocks : Harmonic Inc. (NASDAQ:HLIT), Lexicon Pharmaceuticals (NASDAQ:LXRX), Bona Film Group (NASDAQ:BONA), Grupo Televisa, S.A.B. (NYSE:TV), WSP (NYSE:WH)

Harmonic (NASDAQ:HLIT) CEO Patrick Harshman acquired 10,000 shares of the stock in a transaction dated Friday, August 1st. The stock was purchased at an average price of $5.97 per share, with a total value of $59,700.00. Following the transaction, the chief executive officer now directly owns 334,443 shares in the company, valued at approximately $1,996,625. Harmonic Inc. (NASDAQ:HLIT) belongs to Technology sector. Its net profit margin … Continue reading Trending Stocks : Harmonic Inc. (NASDAQ:HLIT), Lexicon Pharmaceuticals (NASDAQ:LXRX), Bona Film Group (NASDAQ:BONA), Grupo Televisa, S.A.B. (NYSE:TV), WSP (NYSE:WH)

Jason Knox08/1408/14

Biotech Volatile Stocks: Lexicon Pharmaceuticals (NASDAQ:LXRX), Corcept Therapeutics Incorporated (NASDAQ:CORT), Insys Therapeutics (NASDAQ:INSY), ANI Pharmaceuticals (NASDAQ:ANIP)

Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX), just announced a positive, top-line result in a Phase 2 clinical trial of their experimental therapy LX4211 in type 1 diabetes. LX4211, an oral, first-in-class, dual inhibitor of sodium glucose transporters 1 and 2, was designed to lower blood glucose levels through two insulin-independent mechanisms of action. Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) stock performance was 5.16% in last session and finished the … Continue reading Biotech Volatile Stocks: Lexicon Pharmaceuticals (NASDAQ:LXRX), Corcept Therapeutics Incorporated (NASDAQ:CORT), Insys Therapeutics (NASDAQ:INSY), ANI Pharmaceuticals (NASDAQ:ANIP)

Colin Pettis04/1804/18

Notable Moves: Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), Hertz Global (NYSE:HTZ), Advanced Energy Industries, Inc. (NASDAQ:AEIS), Capital Senior Living (NYSE:CSU), National Retail Properties (NYSE:NNN)

Lexicon Pharmaceuticals (NASDAQ:LXRX) was the recipient of a significant increase in short interest in December. As of December 15th, there was short interest totalling 34,102,651 shares, an increase of 9.4% from the November 28th total of 31,182,526 shares, Analyst Ratings.Net reports. Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) belongs to Healthcare sector. Its weekly performance is -1.31%. On last trading day company shares ended up $0.93. Lexicon Pharmaceuticals, … Continue reading Notable Moves: Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), Hertz Global (NYSE:HTZ), Advanced Energy Industries, Inc. (NASDAQ:AEIS), Capital Senior Living (NYSE:CSU), National Retail Properties (NYSE:NNN)

Mark DeFrance01/1601/16

Morning Buzz: Molycorp, Inc. (NYSE:MCP), Staples, Inc. (NASDAQ:SPLS), Gastar Exploration Inc. (NYSEMKT:GST), Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), Waste Management, Inc. (NYSE:WM)

On November 20, 2014, Molycorp, Inc. (NYSE: MCP) entered into an exchange agreement with a holder of the Company’s 6.00% convertible senior notes due 2017 (the “2017 Notes”) and 5.50% convertible senior notes due 2018 (the “2018 Notes”, and together the with the 2017 Notes, the “Notes”) pursuant to which such holder agreed to exchange $27 million in aggregate principal amount of the 2017 Notes … Continue reading Morning Buzz: Molycorp, Inc. (NYSE:MCP), Staples, Inc. (NASDAQ:SPLS), Gastar Exploration Inc. (NYSEMKT:GST), Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), Waste Management, Inc. (NYSE:WM)

Kevin Long11/24